Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis databases.

Tuulikki Sokka1

  • 1Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University, 203 Oxford House, Nashville, TN 37232-4500, USA. tuulikki.sokka@vanderbilt.edu

Rheumatic Diseases Clinics of North America
|October 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.

Annals of the rheumatic diseases·2023
Same author

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.

Annals of the rheumatic diseases·2023
Same author

Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.

Clinical and experimental rheumatology·2022
Same author

Erratum to: Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study.

Rheumatology (Oxford, England)·2021
Same author

Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study.

Rheumatology (Oxford, England)·2020
Same author

Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.

Annals of the rheumatic diseases·2019
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

This review highlights key findings from United States and European rheumatoid arthritis (RA) databases. These registries offer valuable insights into the long-term outcomes of rheumatoid arthritis patients.

Area of Science:

  • Rheumatology
  • Epidemiology
  • Data Science

Background:

  • Rheumatoid arthritis (RA) registers are crucial for longitudinal observational studies.
  • These databases store extensive patient data for long-term outcome analysis.
  • Understanding RA progression requires robust data collection and analysis.

Purpose of the Study:

  • To describe selected computerized RA databases in the US and Europe.
  • To highlight novel observations from these databases regarding long-term RA outcomes.
  • To showcase the utility of RA registries in advancing rheumatological research.

Main Methods:

  • Review of selected computerized RA databases from the United States and Europe.
  • Analysis of data within these registries focusing on longitudinal observational studies.

Related Experiment Videos

  • Identification of key findings related to long-term RA outcomes.

    • Main Results:

    • Description of various RA databases and their functionalities.
    • Presentation of novel observations concerning long-term RA patient outcomes.
    • Demonstration of how these databases contribute to understanding RA progression and management.

    Conclusions:

    • RA registers are invaluable resources for studying long-term disease outcomes.
    • Data from US and European RA databases provide critical insights into rheumatoid arthritis.
    • These databases facilitate advancements in RA research and patient care.